Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
Largest Insider Buys in Sector
BHVN Stock Price History Chart
BHVN Stock Performance
About Biohaven Pharmaceutical Holding Company Ltd.
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The …
Insider Activity of Biohaven Pharmaceutical Holding Company Ltd.
Over the last 12 months, insiders at Biohaven Pharmaceutical Holding Company Ltd. have bought $22.75M and sold $459,663 worth of Biohaven Pharmaceutical Holding Company Ltd. stock.
On average, over the past 5 years, insiders at Biohaven Pharmaceutical Holding Company Ltd. have bought $23.77M and sold $25.62M worth of stock each year.
Highest buying activity among insiders over the last 12 months: CHILDS JOHN W (director) — $12.01M. Coric Vlad (Chief Executive Officer) — $6M. Bailey Gregory (director) — $3.73M.
The last purchase of 21,052 shares for transaction amount of $999,970 was made by Coric Vlad (Chief Executive Officer) on 2024‑10‑02.
List of Insider Buy and Sell Transactions, Biohaven Pharmaceutical Holding Company Ltd.
| 2024-10-02 | Chief Executive Officer | 21,052 0.0215% | $47.50 | $999,970 | +2.94% | |||
| 2024-10-02 | director | 21,052 0.0215% | $47.50 | $999,970 | +2.94% | |||
| 2024-09-24 | director | 5,000 0.0047% | $44.19 | $220,966 | +9.89% | |||
| 2024-07-18 | director | 28,400 0.0218% | $35.67 | $1.01M | +25.30% | |||
| 2024-06-17 | Chief Scientific Officer | 30,000 0.0217% | $33.58 | $1.01M | +24.30% | |||
| 2024-05-30 | director | 28,000 0.0214% | $35.58 | $996,240 | +13.21% | |||
| 2024-05-13 | director | 28,500 0.0215% | $35.17 | $1M | +16.41% | |||
| 2024-05-13 | director | 15,000 0.011% | $34.19 | $512,877 | +16.41% | |||
| 2024-04-24 | director | 25,503 0.0215% | $39.18 | $999,169 | +1.76% | |||
| 2024-04-22 | director | 195,121 0.1719% | $41.00 | $8M | +2.79% | |||
| 2024-04-22 | Chief Executive Officer | 121,951 0.1075% | $41.00 | $5M | +2.79% | |||
| 2024-04-22 | director | 48,780 0.043% | $41.00 | $2M | +2.79% | |||
| 2023-12-29 | Sale | director | 11,000 0.0099% | $41.79 | $459,663 | +1.61% | ||
| 2023-10-05 | director | 454,545 0.2149% | $22.00 | $10M | +61.12% | |||
| 2023-10-05 | Chief Executive Officer | 454,545 0.2149% | $22.00 | $10M | +61.12% | |||
| 2023-10-05 | Chief Financial Officer | 22,727 0.0107% | $22.00 | $499,994 | +61.12% | |||
| 2023-10-04 | director | 17,817 0.0086% | $22.57 | $402,094 | +69.45% | |||
| 2023-08-30 | director | 50,000 0.0198% | $18.44 | $922,180 | +106.32% | |||
| 2023-08-04 | director | 100,000 0.0425% | $19.78 | $1.98M | +84.03% | |||
| 2022-10-31 | Chief Executive Officer | 25,800 0.0089% | $15.97 | $411,995 | +3.92% |
Insider Historical Profitability
| Bailey Gregory | director | 1620071 1.6021% | $36.26 | 9 | 22 | +43.47% |
| Coric Vlad | Chief Executive Officer | 861942 0.8524% | $36.26 | 8 | 8 | +25.36% |
| Car Bruce | Chief Scientific Officer | 30000 0.0297% | $36.26 | 1 | 0 | |
| CHILDS JOHN W | director | 21052 0.0208% | $36.26 | 19 | 2 | +60.31% |
| Cha Albert | director | 1976818 1.9549% | $36.26 | 1 | 0 |